Skip to main content

Table 5 Comparison of the dimension scores of SF-36 (FAS)

From: Zhengtian Capsule versus flunarizine in patients with migraine: a multi-center, double-blind, double-dummy, randomized controlled, non-inferior clinical trial

Dimension

Treatment group

Control group

P value

PF

92.99 ± 9.96

93.972 ± 9.18

0.268

RP

74.00 ± 34.36

74.44 ± 34.75

0.648

BP

71.85 ± 16.90

73.87 ± 17.17

0.171

GH

67.55 ± 15.71

66.70 ± 16.54

0.381

VT

75.96 ± 13.80

76.03 ± 14.48

0.892

SF

81.85 ± 14.59

83.40 ± 15.17

0.127

RE

78.72 ± 35.07

81.29 ± 32.52

0.174

MH

75.66 ± 13.54

74.24 ± 14.39

0.407

MCS

78.05 ± 16.18

78.74 ± 16.02

0.299

PCS

78.57 ± 13.61

78.03 ± 15.12

0.594